sanofi-aventis
New reports from sanofi-aventis detailed
Published in Health Business Week, August 3rd, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at sanofi-aventis.
Report 1: Aventis announced today that the U.S. Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee did not recommend approval rimonabant (ZIMULTI(R)) to the use in obese and overweight patients with associated risks factors.
Sanofi-aventis will continue to work closely with the FDA to address the committee's recommendations.
The FDA has set a PDUFA action date of July 26, 2007 for rimonabant.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2007-08-03)
More Articles from Health Business Week
- Aarp
AARP Calls on President to Release Emergency Funding After Heat Wave Sweeps the Country - Aarp
Divided We Fail: It's Time to Hear about Health and Financial Security in Presidential Debates - Aarp
Status: - Aarp Illinois
Health Care Reform Top Concern for Illinois Voters - Abqaurp
ABQAURP Announces Quality Evaluation Process Conference - Abraxis BioScience, Inc.
Abraxis BioScience and Biocon Limited Announce Licensing Agreement for G-CSF in North America and the European Union - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
